Study of TL-895 Combined With Ruxolitinib in JAKi Treatment-Naïve MF Subjects and Subjects With MF Who Have a Suboptimal Response to Ruxolitinib
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Myelofibrosis
Related studies linked through entity extraction aliases.
A Safety and Tolerability Study of Jaktinib
- Status
- RECRUITING
- Phase
- PHASE1
Study of Tagraxofusp for Post-Transplant Maintenance for Patients With CD 123+ AML, MDS, MF and CMML (HSCT 002)
- Status
- RECRUITING
- Phase
- PHASE1
An Optimal Dose Finding Study of N-Acetylcysteine in Patients With Myeloproliferative Neoplasms
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Elritercept Alone or Together With Ruxolitinib in Adults With Myelofibrosis
- Status
- RECRUITING
- Phase
- PHASE2
Two Step Haplo With Radiation Conditioning
- Status
- RECRUITING
- Phase
- PHASE2
Mutant CALR-peptide Based Vaccine in Patients With Mutated CALR Myeloproliferative Neoplasm
- Status
- RECRUITING
- Phase
- PHASE1
Ropeginterferon Alfa 2b for Early Myelofibrosis
- Status
- RECRUITING
- Phase
- PHASE2
Methods of T Cell Depletion Trial (MoTD)
- Status
- RECRUITING
- Phase
- PHASE2
Jaktinib and Azacitidine In Treating Patients With MDS With MF or MDS/MPN With MF.
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study of Jaktinib In Patients With Myelofibrosis Who Were Relapsed or Refractory of Ruxolitinib Treatment.
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Assess the Safety and Tolerability of BMS-986158 Alone and in Combination With Either Ruxolitinib or Fedratinib in Participants With Blood Cancer (Myelofibrosis)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
- Status
- RECRUITING
- Phase
- PHASE1
Haplo-identical Transplantation in Patients With Myelofibrosis - A Phase 2 Prospective Multicentric Prospective Study
- Status
- UNKNOWN
- Phase
- PHASE2
An Efficacy and Safety Study of Luspatercept (ACE-536) Versus Placebo in Subjects With Myeloproliferative Neoplasm-Associated Myelofibrosis on Concomitant JAK2 Inhibitor Therapy and Who Require Red Blood Cell Transfusions
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Safety and Early Efficacy Study of TBX-2400 in Patients With AML or Myelofibrosis
- Status
- UNKNOWN
- Phase
- PHASE1
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral GB2064 in Participants With Myelofibrosis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study to Evaluate Safety, Pharmacokinetic and Pharmacodynamic Dose Escalation and Expansion Study of PXS-5505 in Patients With Primary, Post-polycythemia Vera or Post-essential Thrombocythemia Myelofibrosis
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
SARS-CoV-2 Donor-Recipient Immunity Transfer
- Status
- COMPLETED
- Phase
- N/A
Study of TL-895 in Subjects With Myelofibrosis or Indolent Systemic Mastocytosis
- Status
- RECRUITING
- Phase
- PHASE2